title: Thyroid cancer: different outcomes to chemotherapy according to tumour histology.
authors.forename: L
authors.initials: L
authors.lastname: Biganzoli
authors.forename: V
authors.initials: V
authors.lastname: Gebbia
authors.forename: L
authors.initials: L
authors.lastname: Maiorino
authors.forename: P
authors.initials: P
authors.lastname: Caraci
authors.forename: A
authors.initials: A
authors.lastname: Iirillo
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D016190:Carboplatin / Q000008:administration & dosage; D002277:Carcinoma / Q000188:drug therapy*; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008875:Middle Aged; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D015251:Epirubicin; D016190:Carboplatin